Cardamyst is now FDA approved as a self-administered intranasal treatment for acute episodes of paroxysmal supraventricular tachycardia.
MedPage Today on MSN
Etripamil Gets FDA Approval for At-Home Tachycardia Conversion
The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), ...
Most wide QRS complex tachycardias (WCTs) are ventricular or supraventricular in origin, but to differentiate between the two can present a diagnostic challenge. To develop and test an algorithm that ...
We reviewed randomized controlled trials, review articles and clinical practice guidelines to present a practical approach to the diagnosis and management of SVTs (Box 1). We focus on the most common ...
Wide complex tachycardia is a general term that refers to conditions that cause an unusually fast heart rate and a particular pattern on an EKG. Tachycardia is when your heart beats unusually fast, ...
Background: Only a few algorithms for predicting the site of origin of focal atrial tachycardia (AT) have been reported. We aimed to develop a new and more effective algorithm. Methods: Surface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results